With the current study design, we are unable to address causation and we suggest that further work is required to explore the functional role of GDF-15 in the known association between T2DM and liver fibrosis in patients with NAFLD. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.